Promising new work is being performed by Dr. Nicola Mason at the University of Pennsylvania School of Veterinary Medicine (Penn Vet) for dogs with osteosarcoma. The study is currently open to dogs with early stages of the disease who have not had any limbs amputated yet. The treatment involves a tumor-targeting vaccine in combination with radiation therapy. The goal of the treatment is to decrease cancer pain and increase the survival rate for dogs with this deadly disease. So far, the trial has shown positive results in terms of limiting the spread of the cancer and prolonging the lives of these dogs.
She is currently recruiting dogs for the study, and can be reached via email at email@example.com or via phone at 3996. For more information, you can go to the Penn Vet website about Dr. Mason’s Canine Cancer Studies here.
Dr. Mason has had success in treating dogs with osteosarcoma who have had amputation and chemotherapy as well. According to the article I found in the Philly Inquirer, “of the first five dogs vaccinated in a previous clinical trial, four have survived over two years since diagnosis and three of these dogs remain completely tumor-free.” You can read more here. These statistics are really impressive.
Knowing that the grim statistics for dogs with osteosarcoma are that sixty percent die within the first year of diagnosis, I’d highly recommend learning more about this study if you are facing this situation with your dog.